Jiayi Lin

885 total citations · 1 hit paper
45 papers, 580 citations indexed

About

Jiayi Lin is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Jiayi Lin has authored 45 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Biomedical Engineering. Recurrent topics in Jiayi Lin's work include Nanoplatforms for cancer theranostics (7 papers), Peptidase Inhibition and Analysis (4 papers) and Ubiquitin and proteasome pathways (4 papers). Jiayi Lin is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Peptidase Inhibition and Analysis (4 papers) and Ubiquitin and proteasome pathways (4 papers). Jiayi Lin collaborates with scholars based in China, United States and Russia. Jiayi Lin's co-authors include Xin Luan, Hongzhuan Chen, Jinmei Jin, Mengjie Li, Yujian Wu, Ye Wu, Chenxia Hu, Dale G. Nagle, Tingting Guo and Xia Huang and has published in prestigious journals such as Chemical Engineering Journal, Journal of Controlled Release and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Jiayi Lin

41 papers receiving 577 citations

Hit Papers

The immunological perspective of major depressive disorde... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayi Lin China 15 348 149 103 81 61 45 580
Heng Zheng United States 10 243 0.7× 116 0.8× 105 1.0× 98 1.2× 51 0.8× 14 535
Shan K. Naidu United States 14 290 0.8× 167 1.1× 59 0.6× 95 1.2× 22 0.4× 22 533
Baozhen Zeng China 11 246 0.7× 201 1.3× 143 1.4× 78 1.0× 60 1.0× 36 617
Yanfang Wang China 17 174 0.5× 176 1.2× 98 1.0× 50 0.6× 91 1.5× 31 577
Hardik Mody United States 12 240 0.7× 219 1.5× 54 0.5× 89 1.1× 48 0.8× 27 447
Subhajit Chatterjee India 15 253 0.7× 173 1.2× 78 0.8× 43 0.5× 43 0.7× 20 447
Yan Zong China 10 353 1.0× 89 0.6× 111 1.1× 83 1.0× 82 1.3× 30 532
Hossam Taha Mohamed Egypt 13 278 0.8× 257 1.7× 125 1.2× 108 1.3× 35 0.6× 24 653
María J. Rico Argentina 12 171 0.5× 252 1.7× 168 1.6× 92 1.1× 44 0.7× 28 533
Xiangjun Tang China 15 309 0.9× 93 0.6× 89 0.9× 119 1.5× 97 1.6× 28 552

Countries citing papers authored by Jiayi Lin

Since Specialization
Citations

This map shows the geographic impact of Jiayi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayi Lin more than expected).

Fields of papers citing papers by Jiayi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayi Lin. The network helps show where Jiayi Lin may publish in the future.

Co-authorship network of co-authors of Jiayi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayi Lin. A scholar is included among the top collaborators of Jiayi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayi Lin. Jiayi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Min, Peng Zhao, Chunling Zhang, et al.. (2025). AI-guided biomaterials and biofabrication strategies for enhanced tumor extracellular matrix mimicry. 2(1). 100188–100188. 2 indexed citations
2.
Sun, Xin, Jiayi Lin, Shengxin Lu, et al.. (2025). Hypoxia-responsive oncolytic conjugate triggers type-II immunogenic cell death for enhanced photodynamic immunotherapy. Journal of Controlled Release. 382. 113717–113717.
3.
Lin, Jiayi, et al.. (2025). Automatic Library Fuzzing through API Relation Evolvement. 1 indexed citations
4.
Lin, Jiayi, Ye Wu, Min Tang, et al.. (2025). A Self‐Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple‐Negative Breast Cancer Therapy. Advanced Science. 12(23). e2500311–e2500311. 3 indexed citations
5.
Lin, Jiayi, et al.. (2025). Gastrointestinal adverse events associated with SNRIs: A FAERS-based pharmacovigilance study. Journal of Affective Disorders. 387. 119484–119484. 1 indexed citations
6.
Wang, Jiao, et al.. (2025). The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms. Journal of Neuroinflammation. 22(1). 10–10. 25 indexed citations breakdown →
7.
Chen, Xinyi, Ziying Wang, Jinmei Jin, et al.. (2024). Dbl family RhoGEFs in cancer: different roles and targeting strategies. Biochemical Pharmacology. 223. 116141–116141. 1 indexed citations
9.
Li, Qingjie, Xueliang Fang, Yingqin Li, et al.. (2024). DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma. Advanced Science. 11(36). e2403262–e2403262. 10 indexed citations
10.
Lin, Jiayi, Yong Guo, Mengxia Chen, et al.. (2024). Thermo-responsive selective recovery of protonated dyes by carbon-doped boron nitride-(N-isopropylacrylamide) composite gel. Journal of Industrial and Engineering Chemistry. 138. 502–515. 1 indexed citations
11.
Liang, Xiaohui, Lu Dong, Jiayi Lin, et al.. (2024). In Silico Discovery of Stapled Peptide Inhibitor Targeting the Nur77‐PPARγ Interaction and Its Anti‐Breast‐Cancer Efficacy. Advanced Science. 11(26). e2308435–e2308435. 7 indexed citations
12.
Wu, Ye, Jiayi Lin, Yudong Zhou, et al.. (2024). Oncolytic Peptide‐Nanoplatform Drives Oncoimmune Response and Reverses Adenosine‐Induced Immunosuppressive Tumor Microenvironment. Advanced Healthcare Materials. 13(26). e2303445–e2303445. 11 indexed citations
13.
Shen, Yiwen, Beibei Zhang, Jing Zhang, et al.. (2024). Integrating single‐cell and spatial analysis reveals MUC1‐mediated cellular crosstalk in mucinous colorectal adenocarcinoma. Clinical and Translational Medicine. 14(5). e1701–e1701. 11 indexed citations
14.
Wei, Sijia, et al.. (2024). The role of enteric nervous system and GDNF in depression: Conversation between the brain and the gut. Neuroscience & Biobehavioral Reviews. 167. 105931–105931. 2 indexed citations
15.
Liu, Xiaoxia, Ting Yang, Jiayi Lin, et al.. (2023). [Stapled anoplin peptide combined with photothermal therapy enhances oncolytic immunotherapy of triple-negative breast cancer].. PubMed. 48(18). 4981–4992. 1 indexed citations
16.
Lin, Jiayi, Haijun Liu, Ye Wu, et al.. (2023). Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer. Small. 19(18). e2207778–e2207778. 24 indexed citations
17.
Jin, Jinmei, Yaping Wu, Ye Wu, et al.. (2022). Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer. JCI Insight. 7(22). 41 indexed citations
18.
Li, Mengjie, Tingting Guo, Jiayi Lin, et al.. (2021). Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway. Journal of Ethnopharmacology. 283. 114689–114689. 76 indexed citations
19.
Lin, Jiayi, Jinmei Jin, Yiwen Shen, et al.. (2021). Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins. Theranostics. 11(17). 8337–8349. 61 indexed citations
20.
Ke, Yang, Yujian Wu, Mengjie Li, et al.. (2020). Curcumin and Glu‐GNPs Induce Radiosensitivity against Breast Cancer Stem‐Like Cells. BioMed Research International. 2020(1). 3189217–3189217. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026